Speedel Holding AG is a Swiss-based drug development company focused on the development of pharmaceuticals that address cardiovascular and metabolic diseases.
Launched in 1998, the Speedel Group is a privately held pharmaceutical company that intends to develop drugs for treating cardiovascular and metabolic diseases.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
All rights reserved. Terms and Conditions | Contact us
